CONSORTIUM

The ProCAncer-I project brings together 20 partners, including PCa centers of reference, world leaders in AI and innovative SMEs, with recognized expertise in their respective domains, with the objective to design, develop and sustain a cloud-based, secure European Image Infrastructure with tools and services for data handling.

Foundation for Research and Technology Hellas (FORTH) COORDINATOR

Greece | Manolis Tsiknakis (Project Coordinator) 

FORTH is the Project Coordinator of ProCAncer-I

RadboudUMC (RUN)

The Netherlands | Jurgen Fütterer

University of Pisa (UNIPI)

Italy | Emanuele Neri

Hacettepe University, School of Medicine, Department of Radiology (HACETTEPE)

Turkey | Deniz Akata

 JCC Diagnostic Imaging (VDC)

Portugal | João Carlos Costa

General Anti-Cancer and Oncological Hospital of Athens, “St. Savvas” (GAONA)

Greece | Vasileios Katsaros

Royal Marsden National Health Service Trust (ICR)

United Kingdom| Dow-Mu Koh

QS Instituto de Investigacion e Innovacion SL (QUIRON)

Spain | Rocio Diaz-Sanchez

Consiglio Nazionale delle Ricerche (CNR)

Italy | Sara Colantonio

ADVANTIS Medical Imaging Single Member PC (ADVANTIS)

Greece | Zoi Giavri

Fundacao D. Anna Sommer Champalimaud e Dr. Carloss Montez Champalimaud (CF)

Portugal | Nikolaos Papanikolaou

Fundacion Para La Investigacion Del Hospital Universitario La Fe De La Comunidad Valenciana (HULAFE)

Spain | Luis Marti Bonmati

Institut Paoli Calmettes (PCAL)

France | Jochen Walz

Fundacio Institut D’Investigacio Biomedica De Girona Doctor Josep Trueta (IDIBGI)

Spain | Joan C. Vilanova

National Cancer Institute (NCIV)

Lithuania | Jurgita Ušinskienė

Candiolo Cancer Institute, FPO – IRCCS (FPO)

Italy | Daniele Regge

Massachusetts General Hospital (The General Hospital Corp) (QTIM)

USA | Jayashree Kalpathy-Cramer

Biotronics 3D Limited (B3D)

UK | Joao Correia

University of Vienna (UNIVIE)

Austria | Nikolaus Forgó

QUIBIM, Sociedad Limitada (QUIBIM)

Spain | Angel ALBERICH-BAYARRI

Highlights

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Open Call To Include New Beneficiaries Into The EUCAIM Consortium

Open Call To Include New Beneficiaries Into The EUCAIM Consortium

The EUCAIM project is launching an open call for new beneficiaries to join the consortium. The objective of the EUCAIM open call is to: i) onboard new cancer image data holders, increasing the geographic dimensions, data modalities or cancer targets, and  ii) include...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I will be organising the 3rd Dissemination Event at the 21st IEEE International Symposium on Biomedical Imaging, which will be held in Athens, Greece, May 27-30, 2024. ProCAncer-I will organise the Workshop “Integrating imaging Data and AI models for...

ProCAncer-I at the ECR 2024 in Vienna

ProCAncer-I at the ECR 2024 in Vienna

A great congress once more! Artificial Intelligence (AI) took the spotlight at the European Radiology Congress (ECR) held at the Austria Center Vienna from February 28 to March 3. Under the theme of 'Next Generation Radiology,' cutting-edge technologies were...

Twitter feed is not available at the moment.

Stay in touch!